Home › Heart Failure › Pennsylvania › Scranton
Heart Failure clinical trials in Scranton, PA
4 studies for Heart Failure are looking for participants at sites in and around Scranton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RecruitingObservational study
- Wilkes-Barre, Wilkes-Barre · 16 mi away
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
RecruitingObservational study
- Geisinger Health System, Wilkes-Barre · 16 mi away
His-Bundle Corrective Pacing in Heart Failure
Recruiting
- Geisinger Wyoming Valley, Wilkes-Barre · 16 mi away
Left vs Left Randomized Clinical Trial
Recruiting
- Geisinger Commonwealth School of Medicine, Scranton
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY50 studies
- Boston, MA43 studies
- Dallas, TX43 studies
- Houston, TX36 studies
- Cleveland, OH33 studies
- Chicago, IL32 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- St. Louis, MO26 studies
- Durham, NC26 studies
- Atlanta, GA25 studies
- Kansas City, MO25 studies
Other studies in Scranton
- Breast Cancer6 studies
- Non-Small Cell Lung Cancer6 studies
- Acute Myeloid Leukemia6 studies
- Lung Cancer6 studies
- Colorectal Cancer5 studies
- Prostate Cancer5 studies
- Bladder Cancer3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Esophageal Cancer3 studies
- Stomach Cancer3 studies
- Colon Cancer3 studies
- Pancreatic Cancer3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.